Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma

MeSH terms

• Antimetabolites, Antineoplastic / adverse effects*
• Bile Duct Neoplasms / drug therapy*
• Bile Ducts, Intrahepatic / drug effects*
• Cholangiocarcinoma / drug therapy*
• Deoxycytidine / adverse effects
• Deoxycytidine / analogs & derivatives*
• Disease Progression
• Gemcitabine
• Hemolytic-Uremic Syndrome / chemically induced*
• Hemolytic-Uremic Syndrome / therapy
• Humans
• Jaundice / chemically induced*
• Male
• Middle Aged
• Prognosis